KT
Pasithea Therapeutics Corp.
KTTAW · NASDAQ
$0.00 +0.00% (+$0.00)
1M -53.95%
Market Cap $26.0K
P/E Ratio -
Div. Yield -
ROE 42.35%
Bulios Fair Price
$0.01
150.0% upside
Trenutna cena
$0.004
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KTTAW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.00x
PEG N/A
P/S N/A
Growth
76 /100
Growing Book val. growth 9.12%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 42.35%
ROA 10.23%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 26.25x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
24 /100
Unstable EPS volatility 53.16%
Profitable years 0
Beta 0.29x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KTTAW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tiago Reis Marques
Employees
5
Headquarters
Miami Beach
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report